ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,721.60
-1.06%
S&P ASX All Technology
3,063.30
-0.61%
Brent Oil
84.02
0.55%
US Dollar vs AUD
1.52096
0.03%
Bitcoin
61,324.20
0.22%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. ADC Therapeutics SA (ADCT)

  7. ADC Therapeutics SA (ADCT) News

ADCT

ADC Therapeutics (ADCT)

ADC Therapeutics SA
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ADCT
DateTimeSourceHeadlineSymbolCompany
09/05/202406:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
08/05/202406:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ADCTADC Therapeutics SA
08/05/202406:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
06/05/202421:30GlobeNewswire Inc.ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded WarrantsNYSE:ADCTADC Therapeutics SA
06/05/202420:51Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
06/05/202420:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ADCTADC Therapeutics SA
06/05/202420:29Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
06/05/202420:10GlobeNewswire Inc.ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
06/05/202420:00GlobeNewswire Inc.ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone LymphomaNYSE:ADCTADC Therapeutics SA
02/05/202406:05GlobeNewswire Inc.ADC Therapeutics Makes Grants to New Employees Under Inducement PlanNYSE:ADCTADC Therapeutics SA
01/05/202421:00GlobeNewswire Inc.ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024NYSE:ADCTADC Therapeutics SA
04/04/202422:00GlobeNewswire Inc.ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaNYSE:ADCTADC Therapeutics SA
03/04/202422:00GlobeNewswire Inc.ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024NYSE:ADCTADC Therapeutics SA
02/04/202407:05GlobeNewswire Inc.ADC Therapeutics Makes Grants to New Employees Under Inducement PlanNYSE:ADCTADC Therapeutics SA
13/03/202422:03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNYSE:ADCTADC Therapeutics SA
13/03/202422:00GlobeNewswire Inc.ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
06/03/202423:15GlobeNewswire Inc.ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes SummitNYSE:ADCTADC Therapeutics SA
06/03/202423:00GlobeNewswire Inc.ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024NYSE:ADCTADC Therapeutics SA
06/03/202409:45GlobeNewswire Inc.ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual MeetingNYSE:ADCTADC Therapeutics SA
06/03/202401:15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
01/03/202408:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
27/02/202423:00GlobeNewswire Inc.ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNYSE:ADCTADC Therapeutics SA
25/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
20/01/202408:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
04/01/202423:15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
04/01/202423:15GlobeNewswire Inc.ADC Therapeutics Regains Compliance with NYSE Continued Listing StandardsNYSE:ADCTADC Therapeutics SA
04/01/202423:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
04/01/202423:00GlobeNewswire Inc.ADC Therapeutics Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
03/01/202412:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ADCTADC Therapeutics SA
03/01/202412:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ADCTADC Therapeutics SA
 Showing the most relevant articles for your search:NYSE:ADCT

Your Recent History

ASX
TLS
Telstra
ASX
RIO
Rio Tinto
FTSE
UKX
FTSE 100
ASX
XFL
S&P ASX 50
NYSE
XOM
Exxon Mobil
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
PM
XAUUSD
Gold vs US Dollar
ASX
XMM
S&P ASX 300 Metals and M...
FX
AUDCAD
AUD vs CAD
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
CBA
Commonwealth Bank Of Aus...
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
ASX
WOW
Woolworths
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved